• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: January 17-21, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

January 17-21, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs1/18/11Silver Spring, MDJanet Woodcock, Karen Midthun, Russell Katz, David Banks, Martha Monser,  Sylvia KimHarry Johns, Robert Egge, Maria Carrillo, Mary Richards (Alzheimer’s Association)Collaborations between FDA and the Alzheimer’s Association
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs1/18/11Silver Spring, MDSeveral FDA officials and staff membersShaun Gilmore and several representatives from American Red CrossAmerican Red Cross
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products1/19/11Rockville, MDSeveral FDA officials and staff membersFrank Hurt, Harry Kaiser, Randy Fulk (Bakery, Confectionary, Tobacco Workers and Grain Millers International Union)Meet and Greet
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products1/19/11Rockville, MDSeveral FDA officials and staff membersLyle Beckwith, Henry O. Armour (National Association of Convenience Stores); Doug Kantor (Steptoe and Johnson); John Manthel (Latham & Watkins)Meet and Greet
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs1/20/11Silver Spring, MDN/ALiz Richardson (University of Edinburgh)Clinical trials conducted outside the United States
Beth Martino, Associate Commissioner for External Affairs1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health1/18/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives of Wright Medical TechnologyMedical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health1/18/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives of Underwriters Laboratories, Inc.Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health1/20/11Washington, DCN/ASeveral representatives of Regulatory Action and Education for Patients (REAP)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health1/21/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives of Cook Group, Inc.Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel1/19/11Silver Spring, MDRick Blumberg, Shannon Singleton, Julie Dohm, Karen SchifterColeen Klasmeier, Eric Shumsky, Sean Griffin, Sara Beardsley (Sidney Austin LLP), Dale Baich (Federal Public Defender AZ)Sodium Thiopental
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs1/17/11-1/21/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research1/17/11-1/21/11N/AN/AN/ANo Significant Meetings